Global Market Study on Dry Eye Syndrome Treatment: Launch of Innovative Treatment Products Complementing Market Growth

Global Market Study on Dry Eye Syndrome Treatment: Launch of Innovative Treatment Products Complementing Market Growth

  • Persistence Market Research
  • March 2021
  • Healthcare
  • 314 pages

Report Description

Dry Eye Syndrome Treatment Market - Scope of Report

A latest publication by Persistence Market Research on the global dry eye syndrome treatment market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the market. The report offers a detailed study of the market background, which includes macroeconomic factors, forecast factors, drivers, restraints, trends, and opportunities in the market. The principal aim of the study is to present exclusive information about how the market will perform over the forecast period of 2020-2030.

Important indicators for successful growth in the dry eye syndrome treatment market are presented in this comprehensive report, which include Year-on-Year (Y-o-Y) growth analysis of the market and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research's study. This research study can support readers to know the demand for dry eye syndrome treatment and quantitative development opportunities during the study period.

The research is beneficial for shareholders in the market, including market investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the dry eye syndrome treatment market. Insights and wisdom presented in this study can be leveraged by shareholders, industry experts, investors, researchers, and reporters, as well as business enthusiasts.

Market statistics as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the dry eye syndrome treatment market are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, under the data submitted in this market report, minor companies and new entrants in the dry eye syndrome treatment industry can be aided in making suitable company choices to achieve traction in market.

Key Market Segments

Persistence Market Researchs study on the dry eye syndrome treatment market offers information divided into four important segments— product, prescription, distribution channel, and region. This report offers comprehensive data and information about important market dynamics and growth parameters associated with these categories.

Product

  • Cyclosporine
  • Topical Corticosteroids
  • Artificial Tears
  • Punctal Plugs
  • Removable
  • Dissolvable
  • Omega Supplements
  • Others

Prescription

  • Rx
  • OTC
  • Medical Device

Distribution Channel

  • Hospital Pharmacies
  • Eye Health Clinics
  • Retail Pharmacies
  • Online Pharmacies

Region

  • North America
  • Latin America
  • Europe
  • South Asia

Key Questions Answered in Report

  • Which regions will continue to remain the most profitable regional markets for dry eye syndrome treatment?
  • Which factors will induce a change in the demand for dry eye syndrome treatment during the assessment period?
  • How will changing trends impact the market?
  • How can market players capture the low-hanging opportunities in developed regions?
  • What are the winning strategies of stakeholders in the dry eye syndrome treatment market to upscale their position in this landscape?
  • What are the restraints that investors need to be aware of and might tackle while investing in the market?
  • What are the developmental trends in ophthalmic sectors that will impact the market?
  • How can businesses avail the growth opportunities in developed and emerging sectors?

Research Methodology

In Persistence Market Researchs study, a unique research methodology is utilized to conduct extensive research on the growth of the dry eye syndrome treatment market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the dry eye syndrome treatment market, and makes Persistence Market Research’s projections on the growth prospects of the market more accurate and reliable.

Keywords

  • Dry Eye Syndrome TreatmentMarket
  • Dry Eye Syndrome TreatmentMarket Share
  • Demand for  Dry Eye Syndrome Treatment
  • Sales of Dry Eye Syndrome Treatment
  • Dry Eye Syndrome TreatmentSales Demand
  • Dry Eye Syndrome TreatmentMarket Forecast
  • Dry Eye Syndrome TreatmentSales Forecast
  • Dry Eye Syndrome TreatmentDemand forecast
  • US Dry Eye Syndrome TreatmentMarket
  • Canada Dry Eye Syndrome TreatmentMarket
  • Europe Dry Eye Syndrome TreatmentMarket
  • Middle East Dry Eye Syndrome Treatmentmarket

Companies Mentioned

  • Allergan Plc.
  • Novartis AG
  • Otsuka Pharmaceutical Co.,Ltd.
  • Santen Pharmaceutical Co Ltd.
  • Bausch Health Companies Inc.
  • Akorn, Inc.
  • Johnson Johnson, Inc.
  • Thea Pharmaceuticals Limited
  • OASIS Medical
  • Altaire Pharmaceuticals Inc.
  • Boiron USA 
  • Similasan Corporation
  • Scope Ophthalmics Ltd.
  • Medicom Healthcare Ltd
  • Reckitt Benckiser Group PLC
  • FDC Limited.
  • Lupin Limited 
  • Jamjoom Pharmaceuticals Co.
  • Sentiss Pharma Private limited

Have query on this report?

Make an Enquiry

Table of Content

1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations

2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion and Exclusions

3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Method Innovation / Development Trends

4. Key Success Factors
4.1. Dry Eye Syndrome Epidemiology, By Country, 2015-2030
4.1.1. Prevalence of dry eye disease 
4.1.2. Potential patient number of dry eye disease
4.1.3. Percentage of severity, mild, modulate, and severe
4.1.4. Patients number under treatment
4.1.5. Prevalence of MGD and occurrence rate of dry eye among MGD patient
4.2. Regulatory Scenario
4.3. New Product Launches
4.4. Reimbursement Scenario
4.5. Dry Eye Syndrome- Diagnostics protocol/ Criteria by key countries
4.6. Dry Eye Syndrome – Patient Treatment Journey

5. Market Background
5.1. Macro-Economic Factors 
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Industry Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Increase in Geriatric Population 
5.2.2. Increasing Prevalence of Dry Eye Syndrome 
5.2.3. Limited Awareness About Dry Eye Syndrome 
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Trends
5.3.4. Opportunity Analysis

6. COVID19 Crisis Analysis
6.1. Current COVID19 Statistics and Probable Future Impact
6.2. Current GDP Projection and Probable Impact
6.3. COVID19 and Impact Analysis
6.3.1. Revenue By Product Type 
6.3.2. Revenue By Distribution Channel 
6.3.3. By Prescription Type
6.3.4. Revenue By Country

7. Global Dry Eye Syndrome Market Demand (In Volume Units) Analysis 2015–2019 and Forecast, 2020–2030
7.1. Historical Market (Volume) Analysis, 2015–2019
7.2. Current and Future Market (Volume) Projections, 2020–2030
7.2.1. Y-o-Y Growth Trend Analysis

8. Global Dry Eye Syndrome Market- Pricing Analysis
8.1. Regional Pricing Analysis By Product

9. Global Dry Eye Syndrome Market  Value (US$ Mn) Analysis 2015-2019 and Forecast, 2020–2030
9.1. Historical Market Value (US$ Mn) Analysis, 2015-2019
9.2. Current and Future Market Value (US$ Mn) Projections, 2020–2030
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis

10. Global Dry Eye Syndrome Market   Analysis 2015-2019 and Forecast 2020–2030, By Product Type 
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) By Product Type, 2015-2019
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2020–2030
10.3.1. Cyclosporin
10.3.2. Topical Corticosteroids
10.3.3. Artificial Tears
10.3.4. Punctal plugs
10.3.4.1. Removable 
10.3.4.2. Dissolvable
10.3.5. Omega Supplements
10.3.6. Others
10.4. Others Market Attractiveness Analysis By Product Type

11. Global Dry Eye Syndrome Market   Analysis 2015-2019 and Forecast 2020–2030, By Prescription Type 
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) By Prescription Type, 2015-2019
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Prescription Type, 2020–2030
11.3.1. Rx
11.3.2. OTC
11.3.3. Medical Device
11.4. Others Market Attractiveness Analysis By Prescription Type

12. Global Dry Eye Syndrome Market   Analysis 2015-2019 and Forecast 2020–2030, By Distribution Channel 
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) By Distribution Channel, 2015-2019
12.3. Current and Future Market Size (US$ Mn)) Analysis and Forecast By Distribution Channel, 2020–2030
12.3.1. Hospital Pharmacies
12.3.2. Eye Health Clinics
12.3.3. Retail Pharmacies
12.3.4. Online Pharmacies
12.4.  Market Attractiveness Analysis By Distribution Channel

13. Global Dry Eye Syndrome Market   Analysis 2015-2019 and Forecast 2020–2030, by Region
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis By Region, 2015 - 2019
13.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2020 - 2030
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. East Asia
13.3.5. South Asia
13.3.6. Oceania
13.3.7. Middle East and Africa (MEA)
13.4. Market Attractiveness Analysis By Region

14. North America Dry Eye Syndrome Market   Analysis 2015-2019 and Forecast 2020–2030
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
14.3. Current and Future Market Size (US$ Mn) Analysis Forecast By Market Taxonomy, 2020–2030
14.3.1.  By Country
14.3.1.1. U.S.
14.3.1.2. Canada
14.3.2. By Product Type
14.3.3. By Prescription Type
14.3.4. By Distribution Channel 
14.4. Market Attractiveness Analysis
14.5. Drivers and Restraints - Impact Analysis

15. Latin America Dry Eye Syndrome Market   Analysis 2015-2019 and Forecast 2020–2030
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015 - 2019
15.3. Current and Future Market Size (US$ Mn) Analysis Forecast By Market Taxonomy, 2020–2030
15.3.1.  By Country
15.3.1.1. Brazil
15.3.1.2. Mexico
15.3.1.3. Rest of Latin America
15.3.2. By Product Type
15.3.3. By Prescription Type
15.3.4. By Distribution Channel 
15.4. Market Attractiveness Analysis
15.5. Drivers and Restraints - Impact Analysis

16. Europe Dry Eye Syndrome Market   Analysis 2015-2019 and Forecast 2020–2030
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
16.3. Current and Future Market Size (US$ Mn) Analysis Forecast By Market Taxonomy 2020–2030
16.3.1. By Country
16.3.1.1. Germany
16.3.1.2. Italy
16.3.1.3. France
16.3.1.4. U.K.
16.3.1.5. Spain
16.3.1.6. Russia
16.3.1.7. Poland
16.3.1.8. Rest of Europe
16.3.2. By Product Type
16.3.3. By Prescription Type
16.3.4. By Distribution Channel 
16.4. Market Attractiveness Analysis
16.5. Drivers and Restraints - Impact Analysis

17. South Asia Dry Eye Syndrome Market   Analysis 2015-2019 and Forecast 2020–2030
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
17.3. Current and Future Market Size (US$ Mn) Analysis By Market Taxonomy2020–2030
17.3.1.  By Country
17.3.1.1. India
17.3.1.2. Thailand
17.3.1.3. Indonesia
17.3.1.4. Malaysia
17.3.1.5. Vietnam
17.3.1.6. Rest of South Asia
17.3.2. By Product Type
17.3.3. By Prescription Type
17.3.4. By Distribution Channel 
17.4. Market Attractiveness Analysis
17.5. Drivers and Restraints - Impact Analysis

18. East Asia Dry Eye Syndrome Market   Analysis 2015-2019 and Forecast 2020–2030
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
18.3. Current and Future Market Size (US$ Mn) Analysis By Market Taxonomy, 2020–2030
18.3.1.  By Country
18.3.1.1. China
18.3.1.2. Japan
18.3.1.3. South Korea
18.3.2. By Product Type
18.3.3. By Prescription Type
18.3.4. By Distribution Channel 
18.4. Market Attractiveness Analysis
18.5. Drivers and Restraints - Impact Analysis

19. Oceania Dry Eye Syndrome Market   Analysis 2015-2019 and Forecast 2020–2030
19.1. Introduction
19.2. Historical Market Size (US$ Mn Analysis By Market Taxonomy, 2015-2019
19.3. Current and Future Market Size (US$ Mn) Analysis By Market Taxonomy, 2020–2030
19.3.1.  By Country
19.3.1.1. Australia
19.3.1.2. New Zealand
19.3.2. By Product Type
19.3.3. By Prescription Type
19.3.4. By Distribution Channel 
19.4. Market Attractiveness Analysis
19.5. Drivers and Restraints - Impact Analysis

20. Middle East and Africa Dry Eye Syndrome Market  Analysis 2015-2019 and Forecast 2020–2030
20.1. Introduction
20.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
20.3. Current and Future Market Size (US$ Mn) Analysis By Market Taxonomy, 2020–2030
20.3.1.  By Country
20.3.1.1. GCC Countries
20.3.1.2. South Africa
20.3.1.3. North Africa
20.3.1.4. Rest of Middle East and Africa
20.3.2. By Product Type
20.3.3. By Prescription Type
20.3.4. By Distribution Channel 
20.4. Market Attractiveness Analysis
20.5. Drivers and Restraints - Impact Analysis

21. Key Countries Dry Eye Syndrome Market   Analysis 2015-2019 and Forecast 2020–2030
21.1. U.S. Dry Eye Syndrome Market   Analysis
21.1.1. By Product Type
21.1.2. By Prescription Type
21.1.3. By Distribution Channel 
21.2. Canada Dry Eye Syndrome Market   Analysis
21.2.1. By Product Type
21.2.2. By Prescription Type
21.2.3. By Distribution Channel 
21.3. Brazil Dry Eye Syndrome Market   Analysis
21.3.1. By Product Type
21.3.2. By Prescription Type
21.3.3. By Distribution Channel 
21.4. Mexico Dry Eye Syndrome Market   Analysis
21.4.1. By Product Type
21.4.2. By Prescription Type
21.4.3. By Distribution Channel 
21.5. U.K. Dry Eye Syndrome Market   Analysis
21.5.1. By Product Type
21.5.2. By Prescription Type
21.5.3. By Distribution Channel 
21.6. Germany Dry Eye Syndrome Market   Analysis
21.6.1. By Product Type
21.6.2. By Prescription Type
21.6.3. By Distribution Channel 
21.7. France Dry Eye Syndrome Market   Analysis
21.7.1. By Product Type
21.7.2. By Prescription Type
21.7.3. By Distribution Channel 
21.8. Italy Dry Eye Syndrome Market   Analysis
21.8.1. By Product Type
21.8.2. By Prescription Type
21.8.3. By Distribution Channel 
21.9. Spain Dry Eye Syndrome Market   Analysis
21.9.1. By Product Type
21.9.2. By Prescription Type
21.9.3. By Distribution Channel 
21.10. Russia Dry Eye Syndrome Market   Analysis
21.10.1. By Product Type
21.10.2. By Prescription Type
21.10.3. By Distribution Channel 
21.11. Poland Dry Eye Syndrome Market   Analysis
21.11.1. By Product Type
21.11.2. By Prescription Type
21.11.3. By Distribution Channel 
21.12. Japan Dry Eye Syndrome Market   Analysis
21.12.1. By Product Type
21.12.2. By Prescription Type
21.12.3. By Distribution Channel 
21.13. China Dry Eye Syndrome Market   Analysis
21.13.1. By Product Type
21.13.2. By Prescription Type
21.13.3. By Distribution Channel 
21.14. South Korea Dry Eye Syndrome Market   Analysis
21.14.1. By Product Type
21.14.2. By Prescription Type
21.14.3. By Distribution Channel 
21.15. India Dry Eye Syndrome Market   Analysis
21.15.1. By Product Type
21.15.2. By Prescription Type
21.15.3. By Distribution Channel 
21.16. Thailand Dry Eye Syndrome Market   Analysis
21.16.1. By Product Type
21.16.2. By Prescription Type
21.16.3. By Distribution Channel 
21.17. Indonesia Dry Eye Syndrome Market   Analysis
21.17.1. By Product Type
21.17.2. By Prescription Type
21.17.3. By Distribution Channel 
21.18. Malaysia Dry Eye Syndrome Market   Analysis
21.18.1. By Product Type
21.18.2. By Prescription Type
21.18.3. By Distribution Channel 
21.19. Vietnam Dry Eye Syndrome Market   Analysis
21.19.1. By Product Type
21.19.2. By Prescription Type
21.19.3. By Distribution Channel 
21.20. Australia Dry Eye Syndrome Market   Analysis
21.20.1. By Product Type
21.20.2. By Prescription Type
21.20.3. By Distribution Channel 
21.21. New Zealand Dry Eye Syndrome Market   Analysis
21.21.1. By Product Type
21.21.2. By Prescription Type
21.21.3. By Distribution Channel 
21.22. GCC Countries Dry Eye Syndrome Market   Analysis
21.22.1. By Product Type
21.22.2. By Prescription Type
21.22.3. By Distribution Channel 
21.23. South Africa Dry Eye Syndrome Market   Analysis
21.23.1. By Product Type
21.23.2. By Prescription Type
21.23.3. By Distribution Channel 

22. Market Structure Analysis
22.1. Market Analysis by Tier of Companies 
22.2. Market Concentration

23. Competition Analysis
23.1. Competition Dashboard
23.2. Competition Deep Dive 
23.2.1. Allergan Plc.
23.2.1.1. Product Portfolio
23.2.1.2. Profitability by Market Segments (Drugs/Channel/Region)
23.2.1.3. Sales Footprint
23.2.1.4. Strategy Overview
23.2.1.4.1. Marketing Strategy
23.2.1.4.2. Product Strategy
23.2.1.4.3. Channel Strategy
23.2.2. Novartis AG
23.2.2.1. Product Portfolio
23.2.2.2. Profitability by Market Segments (Drugs/Channel/Region)
23.2.2.3. Sales Footprint
23.2.2.4. Strategy Overview
23.2.2.4.1. Marketing Strategy
23.2.2.4.2. Product Strategy
23.2.2.4.3. Channel Strategy
23.2.3. Otsuka Pharmaceutical Co.,Ltd.
23.2.3.1. Product Portfolio
23.2.3.2. Profitability by Market Segments (Drugs/Channel/Region)
23.2.3.3. Sales Footprint
23.2.3.4. Strategy Overview
23.2.3.4.1. Marketing Strategy
23.2.3.4.2. Product Strategy
23.2.3.4.3. Channel Strategy
23.2.4. Santen Pharmaceutical Co Ltd.
23.2.4.1. Product Portfolio
23.2.4.2. Profitability by Market Segments (Drugs/Channel/Region)
23.2.4.3. Sales Footprint
23.2.4.4. Strategy Overview
23.2.4.4.1. Marketing Strategy
23.2.4.4.2. Product Strategy
23.2.4.4.3. Channel Strategy
23.2.5. Bausch Health Companies Inc.
23.2.5.1. Product Portfolio
23.2.5.2. Profitability by Market Segments (Drugs/Channel/Region)
23.2.5.3. Sales Footprint
23.2.5.4. Strategy Overview
23.2.5.4.1. Marketing Strategy
23.2.5.4.2. Product Strategy
23.2.5.4.3. Channel Strategy
23.2.6. Akorn, Inc. 
23.2.6.1. Product Portfolio
23.2.6.2. Profitability by Market Segments (Drugs/Channel/Region)
23.2.6.3. Sales Footprint
23.2.6.4. Strategy Overview
23.2.6.4.1. Marketing Strategy
23.2.6.4.2. Product Strategy
23.2.6.4.3. Channel Strategy
23.2.7. Johnson & Johnson, Inc.
23.2.7.1. Product Portfolio
23.2.7.2. Profitability by Market Segments (Drugs/Channel/Region)
23.2.7.3. Sales Footprint
23.2.7.4. Strategy Overview
23.2.7.4.1. Marketing Strategy
23.2.7.4.2. Product Strategy
23.2.7.4.3. Channel Strategy
23.2.8. Thea Pharmaceuticals Limited
23.2.8.1. Product Portfolio
23.2.8.2. Profitability by Market Segments (Drugs/Channel/Region)
23.2.8.3. Sales Footprint
23.2.8.4. Strategy Overview
23.2.8.4.1. Marketing Strategy
23.2.8.4.2. Product Strategy
23.2.8.4.3. Channel Strategy
23.2.9. OASIS Medical
23.2.9.1. Product Portfolio
23.2.9.2. Profitability by Market Segments (Drugs/Channel/Region)
23.2.9.3. Sales Footprint
23.2.9.4. Strategy Overview
23.2.9.4.1. Marketing Strategy
23.2.9.4.2. Product Strategy
23.2.9.4.3. Channel Strategy
23.2.10. Altaire Pharmaceuticals Inc.
23.2.10.1. Product Portfolio
23.2.10.2. Profitability by Market Segments (Drugs/Channel/Region)
23.2.10.3. Sales Footprint
23.2.10.4. Strategy Overview
23.2.10.4.1. Marketing Strategy
23.2.10.4.2. Product Strategy
23.2.10.4.3. Channel Strategy
23.2.11. Boiron USA 
23.2.11.1. Product Portfolio
23.2.11.2. Profitability by Market Segments (Drugs/Channel/Region)
23.2.11.3. Sales Footprint
23.2.11.4. Strategy Overview
23.2.11.4.1. Marketing Strategy
23.2.11.4.2. Product Strategy
23.2.11.4.3. Channel Strategy
23.2.12. Similasan Corporation
23.2.12.1. Product Portfolio
23.2.12.2. Profitability by Market Segments (Drugs/Channel/Region)
23.2.12.3. Sales Footprint
23.2.12.4. Strategy Overview
23.2.12.4.1. Marketing Strategy
23.2.12.4.2. Product Strategy
23.2.12.4.3. Channel Strategy
23.2.13. Scope Ophthalmics Ltd.
23.2.13.1. Product Portfolio
23.2.13.2. Profitability by Market Segments (Drugs/Channel/Region)
23.2.13.3. Sales Footprint
23.2.13.4. Strategy Overview
23.2.13.4.1. Marketing Strategy
23.2.13.4.2. Product Strategy
23.2.13.4.3. Channel Strategy
23.2.14. Reckitt Benckiser Group PLC
23.2.14.1. Product Portfolio
23.2.14.2. Profitability by Market Segments (Drugs/Channel/Region)
23.2.14.3. Sales Footprint
23.2.14.4. Strategy Overview
23.2.14.4.1. Marketing Strategy
23.2.14.4.2. Product Strategy
23.2.14.4.3. Channel Strategy
23.2.15. Medicom Healthcare Ltd 
23.2.15.1. Product Portfolio
23.2.15.2. Profitability by Market Segments (Drugs/Channel/Region)
23.2.15.3. Sales Footprint
23.2.15.4. Strategy Overview
23.2.15.4.1. Marketing Strategy
23.2.15.4.2. Product Strategy
23.2.15.4.3. Channel Strategy
23.2.16. FDC Limited.
23.2.16.1. Product Portfolio
23.2.16.2. Profitability by Market Segments (Drugs/Channel/Region)
23.2.16.3. Sales Footprint
23.2.16.4. Strategy Overview
23.2.16.4.1. Marketing Strategy
23.2.16.4.2. Product Strategy
23.2.16.4.3. Channel Strategy
23.2.17. Lupin Limited 
23.2.17.1. Product Portfolio
23.2.17.2. Profitability by Market Segments (Drugs/Channel/Region)
23.2.17.3. Sales Footprint
23.2.17.4. Strategy Overview
23.2.17.4.1. Marketing Strategy
23.2.17.4.2. Product Strategy
23.2.17.4.3. Channel Strategy
23.2.18. Jamjoom Pharmaceuticals Co. 
23.2.18.1. Product Portfolio
23.2.18.2. Profitability by Market Segments (Drugs/Channel/Region)
23.2.18.3. Sales Footprint
23.2.18.4. Strategy Overview
23.2.18.4.1. Marketing Strategy
23.2.18.4.2. Product Strategy
23.2.18.4.3. Channel Strategy
23.2.19. Sentiss Pharma Private limited 
23.2.19.1. Product Portfolio
23.2.19.2. Profitability by Market Segments (Drugs/Channel/Region)
23.2.19.3. Sales Footprint
23.2.19.4. Strategy Overview
23.2.19.4.1. Marketing Strategy
23.2.19.4.2. Product Strategy
23.2.19.4.3. Channel Strategy

24.  Assumptions and Acronyms Used

25. Research Methodology

List of Table

Table 01: Global Dry Eye Syndrome Treatment Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 02: Global Dry Eye Syndrome Treatment Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Prescription Type
Table 03: Global Dry Eye Syndrome Treatment Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
Table 04: Global Dry Eye Syndrome Treatment Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Region
Table 05: North America Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 06: North America Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 07: North America Dry Eye Syndrome Treatment Volume (000’ Units) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 08: North America Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Prescription Type
Table 09: North America Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
Table 10: Latin America Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 11: Latin America Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 12: Latin America Dry Eye Syndrome Treatment Volume (000’ Units) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 13: Latin America Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Prescription Type
Table 14: Latin America Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
Table 15: Europe Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 16: Europe Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 17: Europe Dry Eye Syndrome Treatment Volume (000’ Units) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 18: Europe Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Prescription Type
Table 19: Europe Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
Table 20: South Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 21: South Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 22: South Asia Dry Eye Syndrome Treatment Volume (000’ Units) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 23: South Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Prescription Type
Table 24: South Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
Table 25: East Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 26: East Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 27: East Asia Dry Eye Syndrome Treatment Volume (000’ Units) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 28: East Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Prescription Type
Table 29: East Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
Table 30: Oceania Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 31: Oceania Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 32: Oceania Dry Eye Syndrome Treatment Volume (000’ Units) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 33: Oceania Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Prescription Type
Table 34: Oceania Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
Table 35: MEA Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 36: MEA Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 37: MEA Dry Eye Syndrome Treatment Volume (000’ Units) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 38: MEA Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Prescription Type
Table 39: MEA Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel

Success Stories

Our Clients